Indsoya (formerly Indsoya Limited) has announced its financial results for the fiscal year 2025, showcasing significant growth in both revenue and profitability.

Financial Highlights

All figures in lakhs, except EPS

Performance Overview

Indsoya has reported a robust financial performance for the year ended March 31, 2025. The company's net profit after tax surged to ₹9.75 lakhs, marking a substantial 60.1% increase from the previous year's ₹6.09 lakhs. This growth was underpinned by a remarkable 207.3% jump in total revenue, which rose to ₹308.20 lakhs from ₹100.30 lakhs in the preceding year.

Quarterly Performance

For the fourth quarter of FY2025, Indsoya reported a net profit of ₹16.40 lakhs, slightly lower than the ₹17.43 lakhs recorded in the same quarter of the previous fiscal year.

Financial Position

As of March 31, 2025, the company maintained a strong liquidity position with cash and cash equivalents of ₹155.72 lakhs. The company's equity share capital remains unchanged at ₹20.00 lakhs, with shares having a face value of ₹5 each.

Audit Opinion

DMKH & Co, the statutory auditors, have issued an unmodified audit opinion on the financial statements, providing assurance on the accuracy and reliability of the reported figures.

Indsoya's significant revenue growth and improved profitability in FY2025 reflect positively on its operational performance and market position. The company's ability to maintain a strong cash position while delivering profit growth suggests effective financial management and operational efficiency.

Indsoya Limited, now known as Apollo Ingredients Limited, has taken a significant step towards ensuring transparency and regulatory compliance for its upcoming rights issue. The company has appointed Infomerics Valuation and Rating Limited as the monitoring agency to oversee the utilization of funds raised through the rights issue.

Appointment Details

The appointment of Infomerics is in line with the Securities and Exchange Board of India (SEBI) Issue of Capital and Disclosure Requirements (ICDR) Regulations, 2018. This move demonstrates Apollo Ingredients' commitment to maintaining high standards of corporate governance and transparency in its financial operations.

About Infomerics

Infomerics Valuation and Rating Limited is a well-established entity in the financial sector:

• SEBI Registration: IN/CRA/00722015 (Perpetual validity)
• Corporate Address: Office No-1102, 1103, 1104 B- Wing, Kanakia Wall Street, off, Andheri- Kurla Rd. Andheri East. Mumbai, Maharashtra-400093
• Website: https://www.infomerics.com/

Consent and Documentation

Infomerics has provided its consent to act as the monitoring agency for Apollo Ingredients Limited's rights issue. The consent letter authorizes the inclusion of Infomerics' name in the following documents:

1. Draft Letter of Offer (DLoF)
2. Letter of Offer (LoF)
3. Other issue-related documents

These documents will be filed with:

• Stock exchanges (BSE and NSE) with nationwide trading terminals
• Registrar of Companies, Mumbai (RoC)
• Securities and Exchange Board of India (SEBI)
• Other relevant regulatory authorities

Regulatory Compliance

The appointment of a monitoring agency is a crucial step in the rights issue process, ensuring that the funds raised are utilized in accordance with the stated objectives. This compliance measure aligns with Section 62 and other applicable provisions of the Companies Act, 2013.

Timeline

Apollo Ingredients Limited, trading under the scrip code 503639 on the BSE, has promptly submitted the consent letter to the stock exchange, demonstrating its commitment to keeping shareholders and regulatory bodies informed about the progress of its rights issue.

This appointment marks an important milestone in Apollo Ingredients Limited's capital raising efforts, providing assurance to investors about the proper utilization of funds and adherence to regulatory standards throughout the rights issue process.